No Data
Regentis Expands Its European Clinical Site Network to Support Its Commercial and Clinical Programs
Express News | Amex Halt Add Info Lst 4.080000
Regentis Biomaterials Appoints Ori Gon as Chief Financial Officer and Chief Business Officer as GelrinC Progresses Towards Commercial Launch in Europe and Advances in U.S. Phase III FDA Trial
Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.
Regentis Biomaterials Shares Halted On Circuit Breaker, Stock Now Down -27.67%
Express News | Amex Halt Add Info Lst 4.810000